Asia Pacific Vaccines Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Vaccines Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Vaccines Market Regional Analysis

6.2 Asia Pacific Vaccines Market Revenue 2016-2027 (US$ Million)

6.3 Asia Pacific Vaccines Market Forecast Analysis

7. Asia Pacific Vaccines Market Analysis – by Technology

7.1 Recombinant Vaccines

7.1.1 Overview
7.1.2 Recombinant Vaccines: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.2 Conjugate Vaccines

7.2.1 Overview
7.2.2 Conjugate Vaccines: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.3 Live Attenuated Vaccines

7.3.1 Overview
7.3.2 Live Attenuated Vaccines: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.4 Inactivated and Subunit Vaccines

7.4.1 Overview
7.4.2 Inactivated and Subunit Vaccines: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.5 Toxoid Vaccines

7.5.1 Overview
7.5.2 Toxoid Vaccines: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

8. Asia Pacific Vaccines Market Analysis – by Disease Indication

8.1 DTP

8.1.1 Overview
8.1.2 DTP: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.2 Influenza

8.2.1 Overview
8.2.2 Influenza: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.3 Hepatitis

8.3.1 Overview
8.3.2 Hepatitis: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.4 Respiratory Syncytial Virus

8.4.1 Overview
8.4.2 Respiratory Syncytial Virus: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.5 Other Diseases

8.5.1 Overview
8.5.2 Other Diseases: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

9. Asia Pacific Vaccines Market Analysis – by Route of Administration

9.1 Oral

9.1.1 Overview
9.1.2 Oral: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

9.2 Injectable

9.2.1 Overview
9.2.2 Injectable: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

9.3 Other Routes of Administration

9.3.1 Overview
9.3.2 Other Routes of Administration: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

10. Asia Pacific Vaccines Market Analysis – by Patient Type

10.1 Pediatric Patients

10.1.1 Overview
10.1.2 Pediatric Patients: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

10.2 Adult Patients

10.2.1 Overview
10.2.2 Adult Patients: Asia Pacific Vaccines Market – Revenue and Forecast, 2016-2027 (US$ Million)

11. Asia Pacific Vaccines Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific

11.2.1 Asia Pacific Vaccines Market Breakdown, by Key Country, 2019 and 2027 (%)
11.2.1.1 Asia Pacific Vaccines Market – Revenue and Forecast Analysis – by Country
11.2.1.1 China: Asia Pacific Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.1.1 China: Asia Pacific Vaccines Market Breakdown, by Technology
11.2.1.1.2 China: Asia Pacific Vaccines Market Breakdown, by Disease Indication
11.2.1.1.3 China: Asia Pacific Vaccines Market Breakdown, by Route of Administration
11.2.1.1.4 China: Asia Pacific Vaccines Market Breakdown, by Patient Type

11.2.1.2 India: Asia Pacific Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.2.1 India: Asia Pacific Vaccines Market Breakdown, by Technology
11.2.1.2.2 India: Asia Pacific Vaccines Market Breakdown, by Disease Indication
11.2.1.2.3 India: Asia Pacific Vaccines Market Breakdown, by Route of Administration
11.2.1.2.4 India: Asia Pacific Vaccines Market Breakdown, by Patient Type

11.2.1.3 Japan: Asia Pacific Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.3.1 Japan: Asia Pacific Vaccines Market Breakdown, by Technology
11.2.1.3.2 Japan: Asia Pacific Vaccines Market Breakdown, by Disease Indication
11.2.1.3.3 Japan: Asia Pacific Vaccines Market Breakdown, by Route of Administration
11.2.1.3.4 Japan: Asia Pacific Vaccines Market Breakdown, by Patient Type

11.2.1.4 Australia: Asia Pacific Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.4.1 Australia: Asia Pacific Vaccines Market Breakdown, by Technology
11.2.1.4.2 Australia: Asia Pacific Vaccines Market Breakdown, by Disease Indication
11.2.1.4.3 Australia: Asia Pacific Vaccines Market Breakdown, by Route of Administration
11.2.1.4.4 Australia: Asia Pacific Vaccines Market Breakdown, by Patient Type

11.2.1.5 Rest of Asia-Pacific : Asia Pacific Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Vaccines Market Breakdown, by Technology
11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Vaccines Market Breakdown, by Disease Indication
11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Vaccines Market Breakdown, by Route of Administration
11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Vaccines Market Breakdown, by Patient Type

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 PFIZER INC

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 GlaxoSmithKline plc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Merck & Co., Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Sanofi

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Johnson & Johnson Services, Inc

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Panacea Biotec Limited

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Astellas Pharma Inc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 NOVAVAX, INC.

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 VBI Vaccines Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Bavarian Nordic

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Asia Pacific Vaccines Market